Fr. 206.00

Atlas of Graft-versus-Host Disease - Approaches to Diagnosis and Treatment

English · Hardback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

This atlas provides trainees and practicing physicians a visual toolkit to help recognize and manage this difficult condition appropriately.  This text highlights the clinical variability of GVHD, and arms readers with the diagnostic clues to categorize patients according to the current grading/staging guidelines.  Furthermore, this atlas offers evidence-based diagnostic and treatment algorithms for physicians to use while at patients' bedsides.

List of contents

Primer on Stem cell transplantation.- Immunology of Acute and Chronic GVHD.- Clinical presentation of cutaneous Acute GVHD.- Clinical presentation of mucosal Acute GVHD.- Grading & Treatment of Acute GVHD.- Clinical presentation of epidermal chronic GVHD.- Clinical presentation of dermal and subcutaneous chronic GVHD.- Clinical presentation of mucosal chronic GVHD.- Grading & Treatment of Chronic GVHD.- Wound care in the management of chronic GVHD.- Flowcharts for grading and treatment of acute and chronic GVHD.

About the author

Dr Cotliar joined the David Geffen School of Medicine at UCLA faculty in 2004 after training there in both internal medicine and dermatology.  While at UCLA, he directed the dermatology inpatient consult service and was heavily involved in the care of bone marrow transplant recipients.  In 2010, he joined the faculty at the Northwestern University Feinberg School of Medicine Department of Dermatology.  While there, he was the Director of the Combined Dermatology-Medicine Training Program, as well as the Director of Clinical Operations within the Dermatology department.  He was also Director of Photopheresis for Northwestern Memorial Hospital, and led the TARGET (Treatment of Adverse Reactions and GVHD EffecTs of Cancer) program.  While at Northwestern, he received a medical dermatology career development award from the Dermatology Foundation to study “Improvement in the diagnosis of acute graft-versus-host disease.”
Dr Cotliar’s clinical and research focus is GVHD and toxicities related to anticancer therapies (both traditional chemotherapeutics and targeted agents).  He has given many talks at national and international dermatology meetings, and has presented posters at ASCO, American Academy of Dermatology Annual Meeting, Society of Investigational Dermatology Annual Meeting, American Society of Bone Marrow Transplantation Annual Meeting, and World Congress of Dermatology.  In 2015, he was recruited to join City of Hope Comprehensive Cancer Center to lead a new Division of Dermatology.

Summary

This atlas provides trainees and practicing physicians a visual toolkit to help recognize and manage this difficult condition appropriately.  This text highlights the clinical variability of GVHD, and arms readers with the diagnostic clues to categorize patients according to the current grading/staging guidelines.  Furthermore, this atlas offers evidence-based diagnostic and treatment algorithms for physicians to use while at patients' bedsides.

Product details

Assisted by Jonatha A Cotliar (Editor), Jonathan A Cotliar (Editor), Jonathan Cotliar (Editor), Jonathan A. Cotliar (Editor)
Publisher Springer, Berlin
 
Languages English
Product format Hardback
Released 31.05.2017
 
EAN 9783319469508
ISBN 978-3-31-946950-8
No. of pages 164
Dimensions 216 mm x 287 mm x 13 mm
Weight 667 g
Illustrations XIV, 164 p. 134 illus. in color.
Subjects Natural sciences, medicine, IT, technology > Medicine > Clinical medicine

A, Medicine, Pediatrics, Oncology, Dermatology, surgical oncology, Paediatric medicine, cancer therapy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.